Clinical Endoscopy (Nov 2023)

Endoscopic vacuum therapy for treatment of spontaneous and iatrogenic upper gastrointestinal defects

  • Kavea Panneerselvam,
  • Jake S. Jacob,
  • Ronald E. Samuel,
  • Andy Tau,
  • Gyanprakash A. Ketwaroo,
  • Wasif M. Abidi,
  • Robert J. Sealock

DOI
https://doi.org/10.5946/ce.2022.177
Journal volume & issue
Vol. 56, no. 6
pp. 754 – 760

Abstract

Read online

Background/Aims Endoscopic vacuum therapy (EVT) can heal a variety of defects within the gastrointestinal (GI) tract via applying negative pressure, which reduces the defect size, aspirates the infected fluid, and promotes granulation tissue. Here we present our experience with EVT as it relates to both spontaneous and iatrogenic upper GI tract perforations, leaks, and fistulas. Methods This retrospective study was conducted at four large hospital centers. All patients who underwent EVT between June 2018 and March 2021 were included. Data on multiple variables were collected, including demographics, defect size and location, number and intervals of EVT exchanges, technical success, and hospital length of stay. Student t-test and the chi-squared test were used to analyze the data. Results Twenty patients underwent EVT. The most common defect cause was spontaneous esophageal perforation (50%). The most common defect location was the distal esophagus (55%). The success rate was 80%. Seven patients were treated with EVT as the primary closure method. The mean number of exchanges was five with a mean interval of 4.3 days between exchanges. The mean length of hospital stay was 55.8 days. Conclusions EVT is a safe and effective initial management option for esophageal leaks and perforations.

Keywords